Ifp Advisors, Inc Tyme Technologies, Inc. Transaction History

Ifp Advisors, Inc

  • $2.42 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 06, 2022
BUY
$0.23 - $0.35 $4,140 - $6,300
18,000 New
18,000 $59,000
Q2 2022

Aug 12, 2022
SELL
$0.23 - $0.35 $4,140 - $6,300
-18,000 Closed
0 $0
Q1 2022

Sep 06, 2022
BUY
$0.28 - $0.68 $1,960 - $4,760
7,000 Added 63.64%
18,000 $6,000
Q1 2021

Apr 30, 2021
BUY
$1.34 - $3.53 $13,400 - $35,300
10,000 Added 1000.0%
11,000 $20,000
Q3 2020

Oct 29, 2020
BUY
$0.93 - $1.35 $930 - $1,350
1,000 New
1,000 $1,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email